Other pharmacological drugs that improve HF survival by targeting endothelial function include ACE inhibitors, β-blockers, type 5 phosphodiesterase (PDE5) inhibitors, and soluble guanylate cyclase (sGC) activators. This evidence concerns the gene ACE and hydrops fetalis.